Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
- DOI
- 10.1182/bloodadvances.2019000893
- Published
- 2019-12-10
- Container
- Blood Advances
- Publisher
- American Society of Hematology
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2019000893,
title = {Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation},
author = {Yi-Bin Chen and Nirav N. Shah and Anne S. Renteria and Corey Cutler and Johan Jansson and Mona Akbari and Chunlin Chen and Syed Quadri and Andrejus Parfionovas and Steven M. Devine},
year = {2019},
journal = {Blood Advances},
doi = {10.1182/bloodadvances.2019000893},
url = {https://doi.org/10.1182/bloodadvances.2019000893}
}RIS
TY - JOUR TI - Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation AU - Yi-Bin Chen AU - Nirav N. Shah AU - Anne S. Renteria AU - Corey Cutler AU - Johan Jansson AU - Mona Akbari AU - Chunlin Chen AU - Syed Quadri AU - Andrejus Parfionovas AU - Steven M. Devine PY - 2019 JO - Blood Advances DO - 10.1182/bloodadvances.2019000893 UR - https://doi.org/10.1182/bloodadvances.2019000893 ER -
APA
Chen, Y., Shah, N. N., Renteria, A. S., Cutler, C., Jansson, J., Akbari, M., Chen, C., Quadri, S., Parfionovas, A., & Devine, S. M. (2019). Vedolizumab for prevention of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Blood Advances. https://doi.org/10.1182/bloodadvances.2019000893
Source records
- crossref · retrieved 2026-09-25T17:25:31.127Z